Document is current
Any future updates will be listed below
-
Authors
Utzschneider, Kristina M https://orcid.org/0000-0002-4924-196X
Younes, Naji
Rasouli, Neda https://orcid.org/0000-0003-1269-3580
Barzilay, Joshua I
Banerji, Mary Ann
Cohen, Robert M
Gonzalez, Erica V
Ismail-Beigi, Faramarz
Mather, Kieren J
Raskin, Philip
Wexler, Deborah J
Lachin, John M https://orcid.org/0000-0001-9838-2841
Kahn, Steven E
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01794143 at ClinicalTrials.govDocuments that mention this clinical trial
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight (Results)
https://doi.org/10.2337/dc19-1769
Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort (Results)
https://doi.org/10.2337/dc20-1787
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)
https://doi.org/10.1161/circulationaha.123.066604
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) (Results)
https://doi.org/10.2337/dc19-0901
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
https://doi.org/10.1016/s0140-6736(14)60794-7
Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin
https://doi.org/10.1136/bmjdrc-2021-002264
Association of Glycemia, Lipids, and Blood Pressure With Cognitive Performance in People With Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
https://doi.org/10.2337/dc20-2858
Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort
https://doi.org/10.1136/bmjdrc-2022-003159
-
Funding
Funding for this research was provided by:
Centers for Disease Control and Prevention (N/A)
American Diabetes Association (N/A)
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK098246)
National Institute of Diabetes and Digestive and Kidney Diseases (U34 DK088043)
National Heart, Lung, and Blood Institute (N/A)
- License Information
